Abstract
Eltrombopag, a thrombopoietin receptor agonist is widely used in the treatment of immune thrombocytopenic purpura (ITP), aplastic anaemia and post-transplant cytopenia. Eltrombopag is used as second-line treatment in ITP. We describe a rare and life-threatening complication of this drug namely cortical venous thrombosis in a patient with ITP. Pathogenetic mechanisms behind the thrombosis may vary from case to case. Thrombosis may be linked to the platelet count or additional thrombophilic states. Regular monitoring of patients on therapy with Eltrombopag is required to avoid these complications.
| Original language | English |
|---|---|
| Pages (from-to) | 221-223 |
| Number of pages | 3 |
| Journal | Journal, Indian Academy of Clinical Medicine |
| Volume | 24 |
| Issue number | 3-4 |
| Publication status | Published - 01-07-2023 |
All Science Journal Classification (ASJC) codes
- General Medicine
Fingerprint
Dive into the research topics of 'Eltrombopag-induced Cortical Vein Thrombosis: A Case Report'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver